333
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

An Evaluation of Practitioner’s Experience of Service Users Seeking Community Detoxification from Benzodiazepines

, M.A., , Ph.D. & , B.A.O.
Pages 224-230 | Received 21 Mar 2017, Accepted 28 Aug 2017, Published online: 04 Dec 2017

References

  • Aldoori, M. I., and S. H. Rahman. 1998. Psychiatry, stigma, and resistance. BMJ 317:763–64.
  • Ashton, H. 1994. The treatment of benzodiazepine dependence. Addiction 89(11):1535–41.
  • Ashton, H. 2005. The diagnosis and management of benzodiazepine dependence. Current Opinion in Psychiatry 18(3):249–55.
  • Ashton, C. H. 2002. Benzodiazepines: How they work and how to withdraw. The Ashton Manual, August.
  • Bellerose, D., A. M. Carew, and S. Lyons. 2011. Treated problem drug use in Ireland 2005 to 2010, HRB trends series 12. Dublin: Health Research Board.
  • Butler, S. 2011. Addiction counsellors in the Republic of Ireland: Exploring the emergence of a new profession. Drugs: Education, Prevention and Policy 18 (4):295–302.
  • Carruth, B., and P. A. Burke. 2006. Psychological trauma and addiction treatment. Journal of Chemical Dependency Treatment 8 (2):1–14.
  • Cannon, R., M. Bozeman, K. R. Miller, J. W. Smith, B. Harbrecht, G. Franklin, and M. Benns. 2014. The prevalence and impact of prescription controlled substance use among injured patients at a Level I trauma center. Journal of Trauma and Acute Care Surgery 76 (1):172–75. doi:10.1097/TA.0b013e3182ab10de.
  • Connolly, J., L. MacGabhann, and M. Olive. 2015. Developing a dual diagnosis service in Cork, Ireland by way of participatory action research (PAR). Advances in Dual Diagnosis 8 (1):29–41. doi:10.1108/ADD-09-2014-0022.
  • Denis, C., M. Fatseas, E. Lavie, and M. Auriacombe. 2006. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. The Cochrane Database of Systematic Reviews3 : no. CD005194.
  • Department of Social and Family Affairs. (2009). National Action plan for social inclusion 2007–2016 annual report 2008. Dublin: Department of Social and Family Affairs, Office for Social Inclusion.
  • Einarson, A., P. Selby, and G. Koren. 2001. Abrupt discontinuation of psychotropic drugs during pregnancy: Fear of teratogenic risk and impact of counselling. Journal of Psychiatry and Neuroscience 26 (1):44.
  • Flores, P. J.. 2001. Addiction as an attachment disorder: Implications for group therapy. International Journal of Group Psychotherapy. 51 (1) Special issue 63–81.
  • Ford, C., J. Fergus Law, B. J. Betterton, and T. Carnwath. 2014. Guidance for the use and reduction of misuse of benzodiazepines and other hypnotics and anxiolytics in general practice. London: SMMGP .
  • Hari, Johann.. 2015. The likely cause of addiction has been discovered, and it is not what you think. The Huffpost.
  • Health Research Board. 2015. 2013 figures from the National Drug Related Deaths Index. http://www.hrb.ie/uploads/tx_hrbpublications/NDRDI_web_update_2004-2013.pdf
  • Health Research Board. 2016. National Drug-Related Deaths Index, 2004 to 2014 data. www.drugsandalcohol.ie/26299
  • Hood, S. D., A. Norman, D. A. Hince, J. K. Melichar, and G. K. Hulse. 2014. Benzodiazepine dependence and its treatment with low dose flumazenil. British Journal of Clinical Pharmacology 77 (2):285–94.
  • Hsieh, H.-F., and S. E. Shannon. 2005. Three approaches to qualitative content analysis. Qualitative Health Research 15 (9):1277–88. doi:10.1177/1049732305276687.
  • Johnson, R. B., and A. J. Onwuegbuzie. 2004. Mixed methods research: A research paradigm whose time has come. Educational Researcher 33 (7):14–26.
  • Kapil, V., J. L. Green, C. Le Lait, D. M. Wood, and P. I. Dargan. 2014. Misuse of benzodiazepines and Z-drugs in the UK. The British Journal of Psychiatry 205 (5):407–08. doi:10.1192/bjp.bp.114.149252.
  • Killeen, T. K., S. E. Back, and K. T. Brady. 2015. Implementation of integrated therapies for comorbid post‐traumatic stress disorder and substance use disorders in community substance abuse treatment programs. Drug and Alcohol Review 34 (3):234–41. doi:10.1111/dar.12229.
  • Lader, M. 2014. Benzodiazepine harm: How can it be reduced? British Journal of Clinical Pharmacology 77 (2):295–301.
  • Liebrenz, M., M.-T. Gehring, A. Buadze, and C. Caflisch. 2015. High-dose benzodiazepine dependence: A qualitative study of patients’ perception on cessation and withdrawal. BMC psychiatry 15 (1):116.
  • Liebrenz, M., M. Schneider, A. Buadze, M.-T. Gehring, A. Dube, and C. Caflisch. 2016. Attitudes towards a maintenance (-agonist) treatment approach in high-dose benzodiazepine-dependent patients: A qualitative study. Harm Reduction Journal 13 (1):1. doi:10.1186/s12954-015-0090-x.
  • Longo, L., and B. Johnson. 2000. Benzodiazepines: Side effects, abuse risk, and alternatives: Addiction part 1. American Family Physician 61:2120–30.
  • Lyons, S. 2010. Guidebook on case management in homeless and drug services. Drugnet Ireland 34:9–10. Summer.
  • MacGabhann, L., A. Scheele, T. Dunne, P. Gallagher, P. MacNeela, G. Moore, and M. Philbin. 2004. Mental health and addiction services and the management of dual diagnosis in Ireland. London: The Stationery Office.
  • McLellan, A. T., J. R. McKay, R. Forman, J. Cacciola, and J. Kemp 2005. Reconsidering the evaluation of addiction treatment: From retrospective follow#up to concurrent recovery monitoring. Addiction 100 (4):447–58.
  • Mehdi, T. 2012. Benzodiazepines revisited. British Journal of Medical Practitioners 5 (1):501.
  • Miller, P. G., and W. R. Miller. 2009. What should we be aiming for in the treatment of addiction? Addiction 104 (5):685–86.
  • Murphy, K., L. Sahm, S. McCarthy, S. Lambert, and S. Byrne. 2013. Substance use in young persons in Ireland, a systematic review. Addictive Behaviors 38 (8):2392–401. doi:10.1016/j.addbeh.2013.03.016.
  • Murphy, K. D., S. Byrne, S. McCarthy, S. Lambert, and L. J. Sahm. 2014. Benzodiazepine use among young attendees of an Irish substance treatment center. Journal of Addiction Medicine 8 (3):199–204. doi:10.1097/ADM.0000000000000025.
  • National Advisory Committee on Drugs and Public Health Information and Research Branch. 2011. Drug use in Ireland and Northern Ireland: First results from the 2010/2011 drug prevalence survey. Bulletin 1. Dublin: National Advisory Committee on Drugs & Public Health Information and Research Branch. http://www.drugsandalcohol.ie/16353/
  • O’Brien, C. P. 2005. Benzodiazepine use, abuse, and dependence. The Journal of Clinical Psychiatry 66 (Suppl 2):28–33.
  • O’Gorman, A., and D. Corrigan. 2008. Report of the HSE working group on residential treatment and rehabilitation (substance users). Dublin: Health Service Executive.
  • Salzman, C. 1990. Benzodiazepine dependency: Summary of the APA task force on benzodiazepines. Psychopharmacol Bull 26 :61–62.
  • Schmitz, A. 2016. Benzodiazepine use, misuse, and abuse: A review. Mental Health Clinician 6 (3):120–26. doi:10.9740/mhc.2016.05.120.
  • Thomas, M. A., T. A. Hagan, M. Levine, K. Meyers, F. Gould, M. Bencivengo, J. Durell, and J. Jaffe. 1999. Does clinical case management improve outpatient addiction treatment. Drug and Alcohol Dependence 55 (1):91–103. doi:10.1016/S0376-8716(98)00183-5.
  • Umbricht, A., and M. L. Velez. 2015. Benzodiazepine abuse and addiction. In Textbook of addiction treatment: international perspectives, 343–65. Milan: Springer.
  • Vogel, M., K. M. Dürsteler-MacFarland, M. Walter, J. Strasser, S. Fehr, L. Prieto, and G. A. Wiesbeck. 2011. Prolonged use of benzodiazepines is associated with childhood trauma in opioid-maintained patients. Drug and Alcohol Dependence 119 (1):93–98. doi:10.1016/j.drugalcdep.2011.05.037.
  • Whiteford, H. A., L. Degenhardt, J. Rehm, A. J. Baxter, A. J. Ferrari, H. E. Erskine, F. J. Charlson, et al. 2013. Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. The Lancet 382 (9904):1575–86. doi:10.1016/S0140-6736(13)61611-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.